This finding would be useful for delineating molecular mechanisms of NETosis, and may be helpful for understanding the alterations in NETosis during autoimmune diseases and in clinical conditions in which these HDAC inhibitors are used for suppressing cell proliferation (e.g., cancer treatments) [19,20]. The gene discussed is HDAC9; the disease is cancer.